Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control.

Liang G, Zhang Q, Yuan M, Yao G, Yuan F

Open source

DOI
10.1038/s41523-026-01013-z
Published
2026 Jul 29
Container
NPJ breast cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41523-026-01013-z,
  title = {Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control.},
  author = {Liang G and Zhang Q and Yuan M and Yao G and Yuan F},
  year = {2026},
  journal = {NPJ breast cancer},
  doi = {10.1038/s41523-026-01013-z},
  url = {https://doi.org/10.1038/s41523-026-01013-z}
}

RIS

TY  - JOUR
TI  - Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control.
AU  - Liang G
AU  - Zhang Q
AU  - Yuan M
AU  - Yao G
AU  - Yuan F
PY  - 2026
JO  - NPJ breast cancer
DO  - 10.1038/s41523-026-01013-z
UR  - https://doi.org/10.1038/s41523-026-01013-z
ER  - 

APA

G, L., Q, Z., M, Y., G, Y., & F, Y. (2026). Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control.. NPJ breast cancer. https://doi.org/10.1038/s41523-026-01013-z

Source records